Extendicare AI Stock Analysis
Extendicare (0S9E) AI Stock Analysis
Extendicare
(LSE:0S9E)
No summary available
Extendicare (0S9E) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- CAD 2.77B
- Dividend Yield
- 1.78%
- Average Volume (3M)
- 164
- Price to Earnings (P/E)
- 20.7
- Beta (1Y)
- -0.04
- Revenue Growth
- 36.24%
- EPS Growth
- 29.85%
- Country
- UK
- Employees
- 23,500
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Extendicare Business Overview & Revenue Model
Company Description
Extendicare Inc. operates across Canada, delivering a wide array of vital care and support services specifically designed for the senior population through its various subsidiaries. The company's diverse service portfolio includes long-term care faci...
Extendicare Earnings Call Summary
The call was strongly positive overall. Extendicare reported substantial year-over-year growth in adjusted EBITDA, revenue, earnings, home health volumes, managed services, liquidity, and deleveraging, while its CBI acquisition and redevelopment program continued to advance. The main challenges were year-over-year Home Health margin pressure, expected moderation in market growth, uncertain Ontario rate timing, redevelopment delays, construction-cost and interest-rate uncertainty, and seasonal volatility. Management nevertheless characterized the company as financially flexible and maintained confidence in long-term demand and its growth opportunities.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management expects underlying Home Health market growth to moderate over time to approximately 6% to 8% on an annualized basis, with funding increases substantially keeping pace with inflation and supporting NOI margins; it continues to expect annualized Managed Services margins of 50% to 55%. CBI finance and enterprise IT systems integration is expected to be completed by January 1, '27, with annualized synergies expected to total approximately $7.4 million by the time CBI is fully integrated in 2028, and synergies more reflective in '28 than in '27. Home Health is viewed as a 13% margin business with an opportunity to grow over time, 50 to another 100 basis points, over the next couple of years, not a 2027 thing. The company plans to open 4 new homes in 2027, bringing a further 832 beds online in the JV, with the next construction start targeted for spring 2027, and expects to review the dividend again early in the first quarter with year-end results.
Extendicare Peers Comparison
Overall Rating
TSE:DR72Outperform
TSE:SIA70Outperform
TSE:CRRX63Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | CAD 276.56M | 8.63 | 44.01% | 2.11% | 4.53% | -55.43% | |
| 70Outperform | CAD 2.27B | 40.44 | 5.98% | 4.58% | 14.90% | 13.31% | |
| 63Neutral | CAD 201.00M | 7.79 | 23.35% | 2.58% | 3.42% | 40560.00% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:0S9E | Extendicare Inc. | 29.19 | 9.71 | 49.88% | |
| TSE:CRRX | Carerx Corporation | 3.18 | -0.13 | -3.96% | |
| TSE:SIA | Sienna Senior Living | 20.43 | 0.86 | 4.41% | |
| TSE:DR | Medical Facilities Corp | 17.10 | 3.07 | 21.85% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
